By monitoring and educating patients and other health care professionals about drug-related adverse effects, pharmacists may help increase medication compliance. Beta-blockers inhibit adverse effects from the sympathetic nervous system, outweighing the negative inotropic effects. Upon physical exam, peripheral edema, pulmonary congestion, or both symptoms may be present.
Pharmacists can help patients identify and alleviate high-risk behaviors such as smoking, alcohol consumption, and illicit and harmful OTC drug use. The newer, long-acting calcium channel blockers amlodipine and felodipine appear to be safe, but no studies have demonstrated a statistically significant reduction in mortality.
Pharmacia Corporation; July She had suffered from dyspepsia, increasing over recent weeks, and the general practitioner had noted a new murmur.
American College of Cardiology Web site. Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the carvedilol or metoprolol European trial COMET: The issues apply across the spectrum of patients seen in clinical practice.
Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction. Eur J Heart Fail. Efficacy and safety of calcium channel blockers in heart failure: Outpatient treatment of systolic heart failure.
ACE inhibitors should be initiated at low doses and slowly titrated based on tolerability of adverse effects. Pharmacologic therapy for patients with chronic heart failure and reduced systolic function: ARBs selectively block angiotensin II by binding to the angiotensin receptor.
The effect of digoxin on mortality and morbidity in patients with heart failure. Less is known about the definition and management of diastolic dysfunction.
Prevention and management of chronic heart failure in management of asymptomatic patients. Some studies demonstrated that coenzyme Q10 led to improvement in the frequency of hospitalizations, dyspnea, and edema.
If patients continue to be symptomatic, digoxin may be added to the standard medication regimen to reduce symptoms, decrease hospitalizations, and enhance exercise tolerance.
Considerations for management of fluid dynamic issues associated with thiazolidinediones. Antiarrhythmic agents, except amiodarone or dofetilide, may cause a cardiodepressant and proarrhythmic effect on the heart, leading to acute decompensation.
Compared to trials of ACE inhibitors, fewer clinical trials have studied the use of ARBs in patients with heart failure; thus, these agents are reserved for patients with demonstrated intolerance of ACE inhibitors.
Fuster V, et al, eds.Swank Pharm Pharmacy Today. Home; Clinical Case Study ~ Heart Failure. swankpharm February 19, Clinical 1 Comment 1, Views. Share. tweet; Related Articles. Natural ways to lower prostate cancer risk.
August 20, Government Tasks Herbal Medicine Practitioners on Cure for Cancer. Case Study #1: Severe The Heart Failure Society of America, Inc. (HFSA) represents the first organized effort by heart failure experts from the Americas to provide a forum for all those interested in heart function, heart failure, and congestive heart failure (CHF) research and patient care.
Pharmacy Case Studies for Pharmacists & Medical Sciences Students Published on March 15, in Pharmacy Case Study Pharmacists and healthcare practitioners are required to demonstrate knowledge and understanding of the application of therapeutics in. Apr 14, · The following case studies have been chosen to illustrate the basis for therapeutic management of systolic heart failure and outline the remaining gaps in knowledge, of which there are several.
The issues apply across the spectrum of patients seen in clinical practice. General treatment algorithm for acute decompensated heart failure (ADHF) based on clinical presentation. IV vasodilators that may be used include nitroglycerin, nesiritide, and nitroprusside.
Metolazone or spironolactone may be added if patient fails to respond to loop diuretics and second diuretic required.
Jentzer, J., Dewald, T., & Hernandez, A. (). Combination of loop diuretics with thiazide-type diuretics in heart failure. Journal of the American College of Cardiology, 56(19), Jonas, B. S. (). Coronary heart disease, smoking and hypertension are the greatest risk factors for congestive heart failure.Download